Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AACR, Abbey, absolute, accomplishment, addiction, adjourned, adjournment, Affymax, Albright, alcoholism, Alpharma, Amgen, AMW, analyst, answer, Anthera, antiproliferative, AON, aromatase, article, Aton, attended, attending, auditor, Austin, Avenue, AWM, Bachelor, background, Banham, Beecham, Bellport, bequest, BIO, Biomedical, BioNJ, Birmingham, Boston, Campaign, capsule, captured, career, categorization, categorized, Cayman, CBI, Centocor, chain, Chairperson, Chiao, CIC, cleaved, CLL, COBRA, College, collusion, Columbia, column, Comapny, comfort, commensurate, complaint, compliant, composed, Confederation, conference, Connecticut, contemplated, contendereto, Cornell, coursework, CPA, CRADA, crime, culture, cum, cure, customarily, customary, CV, CYLACEL, cytotoxic, Daniel, deacetylase, deal, declaratory, deficiency, defray, delegate, delegated, Dendreon, description, deviation, Dexgen, diligence, disability, disaggregation, dissolution, distressed, District, downstream, Druid, DSMB, Eastern, ECI, EGFR, EMAK, ensue, Ernst, erroneously, error, Feesare, fellowship, fiduciary, formula, Fourteen, futility, Geest, gender, Genentech, Geodon, Glasgow, graduate, Greenhouse, Guilford, HDAC, Herceptin, histone, honorary, hormone, Houston, Hradsky, ICI, ICR, identical, Immunex, immunology, Imperial, inclusion, induction, inheritance, injection, insensitive, insight, insufficient, internship, invaluable, Invesco, Iowa, IRA, Iroko, ISTODAX, iv, Japanese, joined, joining, joint, Judy, justified, Kellogg, Kettering, Kingfisher, laude, leadership, lenalidomide, Liposome, Lloyd, LLP, London, Loyola, LS, lump, lymphocytic, Lynx, Marxe, Maryland, Master, membership, Memorial, Mersana, MGP, MLL, Monday, myeloma, Naurex, negligence, Neuroscience, nominate, nominated, Nominating, nomination, nominee, Noopur, Nova, obese, occupation, ofnolo, omission, Oncothyreon, OS, OSI, OTC, outlined, override, overseeing, page, pairwise, pancreatic, PARP, pathology, payout, Pennsylvania, permanent, permissible, Pink, plea, political, postdoctoral, predetermined, prespecified, prevailing, Prognostic, promptly, proportional, QP, quorum, race, Radford, Raje, rata, reassessed, recipient, Red, reissuance, relocate, relocation, reorganization, restored, romidepsin, Rowe, safeguard, scored, Scoring, seat, Secretary, Selectica, session, Shire, Sielox, Silence, simulation, Sloan, SmithKline, software, sound, Spiegelman, SPOR, Squibb, Stanford, sterling, stimulatory, subdivision, successor, Sultan, summa, survey, synergistically, tabular, Takmira, Tarceva, Tarmac, Tekmira, TerminationWithout, text, tied, topline, traditionally, traffic, trastuzumab, Treasurer, trust, UBS, unblinding, undeclared, unearned, unexercised, Upjohn, venture, verification, vitro, waiver, wanton, Watchpoint, Wharton, Whitbread, Yale, York, Young, Zeneca, Zolinza, Zoloft
Removed:
absent, acceleration, activation, adjust, adult, allocating, allocation, annum, attainment, Babraham, bank, blackout, collectively, comparative, compare, Composite, concurrently, condensed, consummation, converting, declining, decreasing, deliver, desired, deteriorate, discontinued, Discretionary, divide, embedded, employ, executed, exit, exposure, FAS, feature, filled, foundation, graph, hypothetical, identifiable, improbable, inadequate, incremental, indefinite, indexed, inhibit, interacting, judged, leader, minimal, Moody, movement, multiply, operated, organized, overabundance, passage, polo, predefined, preservation, principally, realizing, recognizing, reinvestment, renamed, replacement, reportable, retranslated, ruling, SEIP, Similarly, soliciting, split, step, subleasing, suppressor, tangible, transition, underwriting, unqualified, variously, voluntary, waived
Filing tables
Filing exhibits
Related press release
CYCC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-143786) pertaining to the 2006 Equity Incentive Plan of Cyclacel Pharmaceuticals, Inc. of our report dated March 31, 2011, with respect to the consolidated financial statements of Cyclacel Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP |
London, England
March 31, 2011
March 31, 2011